WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Earnings & Revenue

CTKB past revenue growth

How has CTKB's revenue growth performed historically?
Company
18.45%
Industry
8.62%
Market
17.81%
CTKB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTKB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CTKB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CTKB earnings and revenue history

Current Revenue
$183.1M
Current Earnings
-$14.1M
Current Profit Margin
-7.7%

CTKB Return on Equity

Current Company
-3.3%
Current Industry
8%
Current Market
-8.4%
CTKB's Return on Equity (-3.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CTKB announces earnings.

CTKB Return on Assets

Current Company
-2.7%
Current Industry
4.6%
CTKB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTKB Return on Capital Employed

Current Company
-2.94%
Current Industry
7.2%

CTKB vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTKB$183.12M-$4.86M-$14.12M+23.70%N/A
FNA$207.34M-$48.23M-$67.05M+21.81%N/A
AHCO$3.12B$112.41M-$426.98M+30.20%N/A
PACB$169.52M-$286.01M-$309.10M+15.07%N/A
ESTA$177.40M-$50.39M-$71.52M+25.66%N/A

CTKB earnings dates

Next earnings date
Feb 28, 2024

Cytek Biosciences Earnings & Revenue FAQ

What were CTKB's earnings last quarter?

On Invalid Date, Cytek Biosciences (NASDAQ: CTKB) reported Q3 2023 earnings per share (EPS) of -$0.05, up 600% year over year. Total Cytek Biosciences earnings for the quarter were -$6.46 million. In the same quarter last year, Cytek Biosciences's earnings per share (EPS) was $0.01.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.

What was CTKB's earnings growth in the past year?

As of Q1 2024, Cytek Biosciences's earnings has grown year over year. Cytek Biosciences's earnings in the past year totalled -$14.12 million.

What is CTKB's earnings date?

Cytek Biosciences's earnings date is Invalid Date. Add CTKB to your watchlist to be reminded of CTKB's next earnings announcement.

What was CTKB's revenue last quarter?

On Invalid Date, Cytek Biosciences (NASDAQ: CTKB) reported Q3 2023 revenue of $48.00 million up 18.59% year over year. In the same quarter last year, Cytek Biosciences's revenue was $40.48 million.

What was CTKB's revenue growth in the past year?

As of Q1 2024, Cytek Biosciences's revenue has grown 18.45% year over year. This is 9.83 percentage points higher than the US Medical Devices industry revenue growth rate of 8.62%. Cytek Biosciences's revenue in the past year totalled $183.12 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.